AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioCardia's President to Present at H. C. Wainwright 27th Annual Global Investment Conference.
ByAinvest
Thursday, Sep 4, 2025 9:03 am ET1min read
BioCardia's President and CEO, Peter Altman, PhD, will present a corporate update at the H. C. Wainwright 27th Annual Global Investment Conference. He will discuss the company's progress toward milestones, including its three clinical cell therapy programs for ischemic heart disease and regulatory activities seeking FDA and Japan PMDA approval for CardiAMP cell therapy for heart failure. Additionally, he will detail the recent partnership to develop and commercialize Heart3D fusion imaging and the status of the nondilutive funding for CardiALL.
BioCardia, Inc. [NASDAQ:BCDA], a leading developer of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, has announced that its President and CEO, Peter Altman, PhD., will present a corporate update at the H. C. Wainwright 27th Annual Global Investment Conference. The event will take place from September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.Dr. Altman will present in person at 2:00 PM ET on Wednesday, September 10, 2025. He will discuss the company's progress towards various milestones, including its three clinical cell therapy programs for ischemic heart disease. Additionally, he will provide updates on regulatory activities seeking FDA approval and Japan PMDA approval for CardiAMP® cell therapy for heart failure.
The presentation will also cover the recent partnership to develop and commercialize Heart3D fusion imaging and the status of the nondilutive funding for the CardiALLO™ allogeneic mesenchymal stem cell program for the treatment of heart failure. Dr. Altman will be available for one-on-one meetings with investors during the conference.
The H. C. Wainwright Global Investment Conference is a prominent event for investors and financial professionals, offering insights into various sectors, including biotechnology. For more information about the conference, visit [H. C. Wainwright Global Investment Conference](https://hcwevents.com/annualconference/).
References:
[1] https://www.stocktitan.net/news/BCDA/bio-cardia-ceo-peter-altman-to-present-at-the-h-c-wainwright-27th-px6max5jkxjx.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet